PUMD Insider Trading Activity and SEC Form 4 Filings
PUMD insider trading summary
No open-market insider purchases or sales of ProUroCare Medical Inc. (PUMD) have been reported on SEC Form 4 in the past 12 months.
Latest PUMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 13, 2013 | James L Davis | Director | Buy | $450 (2,500 @ $0.18) |
| Sep 3, 2013 | James L Davis | Director | Buy | $575 (2,500 @ $0.23) |
| Sep 3, 2013 | James L Davis | Director | Buy | $575 (2,500 @ $0.23) |
| Aug 30, 2013 | James L Davis | Director | Buy | $750 (2,500 @ $0.30) |
| Aug 27, 2013 | James L Davis | Director | Buy | $1K (3,500 @ $0.35) |
| Jul 1, 2010 | James L Davis | Director | Buy | $5K (3,021 @ $1.60) |
| Jul 1, 2010 | Michael Chambers | Director | Buy | $5K (3,334 @ $1.60) |
| Jul 1, 2010 | Scott E Smith | Director | Buy | $8K (5,000 @ $1.60) |
| Jul 1, 2010 | Robert James Rudelius | Director | Buy | $9K (5,469 @ $1.60) |
| Jul 1, 2010 | David Koenig | Director | Buy | $10K (5,938 @ $1.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.